Laurel J. Steinherz

TL;DR: The 23% incidence of late cardiac abnormalities warrants continued evaluation of patients after anthracyclines to guide patient care and the design of future chemotherapeutic protocols.

TL;DR: Recommendations for standardized noninvasive monitoring of children during and immediately after chemotherapy and for the modification of the chemotherapy where indicated are formulated.

TL;DR: Clofarabine is active as a single agent in pediatric patients with multiple relapsed or refractory ALL and the toxicity profile is as expected in this heavily pretreated patient population.

TL;DR: Excerpt Although a significant problem in Latin America, the transmission of Trypanosoma cruziinfection by transfusion has not been unequivocally documented in the United States, and a caseload of cases is reported.

TL;DR: The authors' patients with early cardiac symptoms improved transiently but decompensated later and patients with no early symptoms developed cardiac symptoms more than 10 years after anthracycline therapy, therefore, patients who have received anthRacyclines should have continued cardiac evaluation.